Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Marksans Pharm Marksans Pharma Ltd. | BSE 172.95 0.15 (0.09%) | NSE 173.55 0.57 (0.33%) | Trade | Add

BSE Live

Jan 13, 16:01

172.95 0.15 (0.09%)

Volume

AVERAGE VOLUME

5-Day

36,469

10-Day

33,244

30-Day

39,719

15,931

Prev. Close

172.80
Open Price

172.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 13, 15:59

173.55 0.57 (0.33%)

Volume

AVERAGE VOLUME

5-Day

788,773

10-Day

637,650

30-Day

657,899

438,132

Prev. Close

172.98
Open Price

173.94

Bid Price (Qty.)
173.55 (100)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Marksans Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	2.67	1.87	1.19	-4.86	-6.07
Diluted EPS (Rs.)	2.67	1.87	1.19	-4.86	-6.07
Cash EPS (Rs.)	3.13	2.32	1.67	-4.14	-5.48
Book Value [ExclRevalReserve]/Share (Rs.)	9.17	3.51	2.08	-4.94	-2.14
Book Value [InclRevalReserve]/Share (Rs.)	9.17	3.51	2.08	-4.94	-2.14
Revenue from Operations/Share (Rs.)	19.46	16.35	11.38	9.67	8.28
PBDIT/Share (Rs.)	4.59	3.15	1.92	-2.66	-1.95
PBIT/Share (Rs.)	4.20	2.74	1.51	-3.30	-2.49
PBT/Share (Rs.)	3.81	2.24	1.13	-4.76	-3.68
Net Profit/Share (Rs.)	2.74	1.91	1.27	-4.79	-6.03
NP After MI And SOA / Share (Rs.)	2.67	1.87	1.19	-4.86	-6.07
Profitability Ratios
PBDIT Margin (%)	23.60	19.24	16.83	-27.48	-23.50
PBIT Margin (%)	21.58	16.75	13.26	-34.15	-30.06
PBT Margin (%)	19.56	13.71	9.93	-49.22	-44.39
Net Profit Margin (%)	14.05	11.68	11.13	-49.52	-72.84
NP After MI And SOA Margin (%)	13.73	11.41	10.46	-50.29	-73.29
Return on Networth/Equity (%)	29.78	55.87	62.87	0.00	0.00
Return on Capital Employed (%)	28.09	42.05	44.13	90.48	328.24
Return on Assets (%)	16.19	14.67	11.43	-46.04	-45.38
Total Debt/Equity (X)	0.22	0.97	1.67	-0.71	-1.72
Asset Turnover Ratio (%)	117.93	128.54	109.26	91.55	61.91
Liquidity Ratios
Current Ratio (X)	1.78	1.07	0.82	0.42	0.40
Quick Ratio (X)	1.32	0.75	0.56	0.28	0.27
Inventory Turnover Ratio (X)	6.12	6.14	5.64	4.85	4.53
Dividend Payout Ratio (NP) (%)	5.28	13.36	10.19	-0.15	0.00
Dividend Payout Ratio (CP) (%)	4.60	10.96	7.60	-0.17	0.00
Earnings Retention Ratio (%)	94.72	86.64	89.81	100.15	0.00
Cash Earnings Retention Ratio (%)	95.40	89.04	92.40	100.17	0.00
Coverage Ratios
Interest Coverage Ratios (%)	10.72	5.52	3.98	-2.27	-2.10
Interest Coverage Ratios (Post Tax) (%)	10.72	5.52	3.98	-2.27	-2.10
Valuation Ratios
Enterprise Value (Cr.)	2,440.94	1,021.35	276.54	180.93	200.32
EV/Net Operating Revenue (X)	3.06	1.62	0.63	0.51	0.66
EV/EBITDA (X)	12.98	8.42	3.75	-1.85	-2.80
MarketCap/Net Operating Revenue (X)	3.17	1.46	0.34	0.17	0.27
Retention Ratios (%)	94.71	86.63	89.80	100.15	0.00
Price/BV (X)	6.87	7.17	2.06	-0.33	-1.05
Price/Net Operating Revenue	3.17	1.46	0.34	0.17	0.27
Earnings Yield	0.04	0.08	0.31	-2.95	-2.70